Results 41 to 50 of about 2,054,122 (239)

Multi-Modality Imaging of the Tricuspid Valve: From Tricuspid Valve Disease to Catheter-Based Interventions

Reviews in Cardiovascular Medicine, 2022
Tricuspid valve disease represents a major health problem that affects a wide proportion of heart failure patients with a significant prognostic impact.
Fabio Fazzari, Francesco Cannata, Matteo Maurina, Renato Maria Bragato, Marco Francone   +4 more
doaj   +1 more source

Echocardiographic guidance in transcatheter tricuspid valve interventions. [PDF]

J Cardiovasc Imaging
Echocardiographic guidance plays a pivotal role in pre-procedural screening and intraprocedural guidance for transcatheter tricuspid valve interventions (TTVI).
Kam KKH, Vannan M, Lee APW.
europepmc   +2 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?

Life, 2023
Tricuspid regurgitation (TR) is a common valvular pathology, estimated to affect 1.6 million people in the United States alone. Even though guidelines recommend either medical therapy or surgical treatment for TR, the misconception of TR as a benign disease along with the high mortality rates of surgical intervention led to undertreating this disease ...
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Aznaouridis, Panagiotis Iliakis, Aggeliki Valatsou, Panagiotis Tsioufis, Eirini Beneki, Emmanouil Mantzouranis, Konstantina Aggeli, Eleftherios Tsiamis, Konstantinos Tsioufis   +10 more
openaire   +4 more sources

Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment [PDF]

, 2019
Most patients with severe tricuspid regurgitation lack treatment options because of prohibitive surgical risk. New transcatheter treatments under development and investigation might be able to address this unmet clinical need.
Jonathan Curio, Ozan M Demir, Antonio Mangieri, Francesco Giannini, Azeem Latib, Giora Weisz, Matteo Pagnesi   +6 more
core   +1 more source

Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Tricuspid regurgitation (TR) frequently develops in patients with long‐standing pulmonary hypertension, and both pathologies are associated with increased morbidity and mortality.
Vera Fortmeier, Mark Lachmann, Matthias Unterhuber, Lukas Stolz, Mohammad Kassar, Laurin Ochs, Muhammed Gerçek, Anne R. Schöber, Thomas J. Stocker, Hazem Omran, Maria I. Körber, Amelie Hesse, Kai Peter Friedrichs, Shinsuke Yuasa, Tanja K. Rudolph, Michael Joner, Roman Pfister, Stephan Baldus, Karl‐Ludwig Laugwitz, Fabien Praz, Stephan Windecker, Jörg Hausleiter, Philipp Lurz, Volker Rudolph   +23 more
doaj   +1 more source

Mitral and Tricuspid Transcatheter Interventions Current Indications and Future Directions. [PDF]

, 2020
Valvular heart disease is responsible for a high rate of morbidity and mortality, especially in the elderly population. With the emergence of new transcatheter treatment options, the therapeutic spectrum for patients with valvular heart disease has ...
Winkel, Mirjam Gauri, Praz, Fabien, Wenaweser, Peter Martin   +2 more
core   +2 more sources

The promise and pitfalls of registries for transcatheter tricuspid valve intervention.

EuroIntervention
Rebecca T. Hahn
semanticscholar   +3 more sources

Real-Time Monitoring and Step-by-Step Guidance for Transcatheter Tricuspid Annuloplasty Using Transesophageal Echocardiography

Journal of Cardiovascular Development and Disease, 2022
Transcatheter tricuspid valve intervention (TTVI) is a novel alternative to functional tricuspid regurgitation (FTR) for patients with prohibitive surgical risk.
Yu Liu, Wei Li, Daxin Zhou, Xiaochun Zhang, Dehong Kong, Zhenyi Ge, Haiyan Chen, Xianhong Shu, Cuizhen Pan, Junbo Ge   +9 more
doaj   +1 more source

Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR).
Wang Wei, Li Ning, Li Ning, Ning Xiaoping, Xu Zhiyun, Li Bailing, Cai Chengliang, Yang Fan, Zhou Guangwei, Bai Yifan, Han Lin, Qiao Fan, Lu Fanglin   +12 more
doaj   +1 more source